Publicaciones en colaboración con investigadores/as de National Cancer Institute (20)

2016

  1. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage

    Cancer Cell, Vol. 30, Núm. 5, pp. 806-821

2013

  1. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 45, pp. 18250-18255

2006

  1. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis

    American Journal of Pathology, Vol. 168, Núm. 1, pp. 280-291

  2. Adrenomedullin: An Esoteric Juggernaut of Human Cancers

    Handbook of Biologically Active Peptides (Elsevier Inc.), pp. 453-458

2004

  1. Expression of complement factor H by lung cancer cells: Effects on the activation of the alternative pathway of complement

    Cancer Research, Vol. 64, Núm. 17, pp. 6310-6318

2003

  1. Mapping of the adrenomedullin-binding domains in human complement factor H

    Hypertension Research, Vol. 26, Núm. SUPPL.

  2. Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo

    Molecular and Cellular Endocrinology, Vol. 199, Núm. 1-2, pp. 179-187

2002

  1. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis

    Microscopy Research and Technique, Vol. 57, Núm. 2, pp. 110-119

  2. Deregulated expression of the PCPH proto-oncogene in rat mammary tumors induced with 7, 12-dimethylbenz[a]anthracene

    Molecular Carcinogenesis, Vol. 33, Núm. 4, pp. 219-227

  3. Identification, characterization, and physiological actions of factor H as an adrenomedullin binding protein present in human plasma

    Microscopy Research and Technique, Vol. 57, Núm. 1, pp. 23-27

  4. The effects of adrenomedullin overexpression in breast tumor cells

    Journal of the National Cancer Institute, Vol. 94, Núm. 16, pp. 1226-1237

2001

  1. Cancer and diabetes: Two pathological conditions in which adrenomedullin may be involved

    Peptides, Vol. 22, Núm. 11, pp. 1719-1729

  2. Complement Factor H Is a Serum-binding Protein for Adrenomedullin, and the Resulting Complex Modulates the Bioactivities of Both Partners

    Journal of Biological Chemistry, Vol. 276, Núm. 15, pp. 12292-12300

  3. Evidence for pigment epithelium-derived factor receptors in the neural retina

    Investigative Ophthalmology and Visual Science, Vol. 42, Núm. 13, pp. 3287-3293

  4. Expression of the adrenomedullin binding protein, complement factor H, in the pancreas and its physiological impact on insulin secretion

    Journal of Endocrinology, Vol. 170, Núm. 3, pp. 503-511

  5. Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines

    Radiation Research, Vol. 155, Núm. 1, pp. 181-187

  6. Presence of immunoreactive adrenomedullin in human and bovine milk

    Peptides, Vol. 22, Núm. 12, pp. 1859-1863

2000

  1. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis

    Molecular Endocrinology, Vol. 14, Núm. 6, pp. 848-862

1999

  1. Is adrenomedullin a causal agent in some cases of type 2 diabetes?

    Peptides, Vol. 20, Núm. 12, pp. 1471-1478

  2. Underlying disease stress augments plasma and tissue adrenomedullin (AM) responses to endotoxin: Colocalized increases in AM and inducible nitric oxide synthase within pancreatic islets

    Endocrinology, Vol. 140, Núm. 11, pp. 5402-5411